Literature DB >> 10954269

Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions.

S O Casey1, R C Sampaio, E Michel, C L Truwit.   

Abstract

BACKGROUND AND
PURPOSE: Posterior reversible encephalopathy syndrome (PRES) is typically characterized by headache, altered mental functioning, seizures, and visual loss associated with imaging findings of bilateral subcortical and cortical edema with a predominantly posterior distribution. Our goal was to determine whether fluid-attenuated inversion recovery (FLAIR) imaging improves the ability to detect subtle peripheral lesions of PRES, as compared with conventional MR techniques.
METHODS: Sixteen patients with clinical and imaging findings consistent with PRES were studied. Thirteen patients had undergone transplantation and had cyclosporin A neurotoxicity. Fast-FLAIR images were compared with spin-echo proton density- and T2-weighted images.
RESULTS: FLAIR imaging improved diagnostic confidence and conspicuity of the T2 hyperintense lesions of PRES, typically in the subcortical white matter of the parietooccipital regions bilaterally. On all 23 abnormal MR studies, FLAIR was judged superior to proton density- and T2-weighted images for the detection of PRES in the supratentorial brain. In a mean of 6.7 of 23 studies, FLAIR findings prompted a raise in the grade of disease severity. FLAIR also showed cortical involvement in 94% of patients with PRES and in a mean of 46% of the total lesion burden. In four cases, subtle lesions were virtually undetectable without FLAIR. Brain stem or cerebellar disease was encountered in 56% of patients.
CONCLUSION: FLAIR improves the ability to diagnose and detect subcortical and cortical lesions in PRES as compared with proton density- and T2-weighted spin-echo images. We therefore believe that FLAIR should be performed in patients with suspected PRES to allow more confident recognition of the often subtle imaging abnormalities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954269      PMCID: PMC8174901     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  31 in total

1.  A reversible posterior leukoencephalopathy syndrome.

Authors:  R B Schwartz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

2.  Posterior leukoencephalopathy without severe hypertension: utility of diffusion-weighted MRI.

Authors:  H Ay; F S Buonanno; P W Schaefer; D A Le; B Wang; R G Gonzalez; W J Koroshetz
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

3.  The reversible posterior cerebral edema syndrome.

Authors:  W P Dillon; H Rowley
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Regional cerebral blood flow in acute experimental hypertension.

Authors:  B Johansson
Journal:  Acta Neurol Scand       Date:  1974       Impact factor: 3.209

5.  Cerebral magnetic resonance angiographic findings in severe preeclampsia.

Authors:  Y Matsuda; T Tomosugi; Y Maeda; M Kamitomo; N Kanayama; T Terao
Journal:  Gynecol Obstet Invest       Date:  1995       Impact factor: 2.031

6.  Cyclosporine-related reversible posterior leukoencephalopathy: MRI.

Authors:  J M Jarosz; D C Howlett; T C Cox; J B Bingham
Journal:  Neuroradiology       Date:  1997-10       Impact factor: 2.804

7.  Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases.

Authors:  R B Schwartz; S M Bravo; R A Klufas; L Hsu; P D Barnes; C D Robson; J H Antin
Journal:  AJR Am J Roentgenol       Date:  1995-09       Impact factor: 3.959

8.  Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging.

Authors:  K Weingarten; D Barbut; C G Filippi; C Filippi; R D Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1994-03       Impact factor: 3.959

9.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

View more
  143 in total

1.  Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

Authors:  J M Provenzale; J R Petrella; L C Cruz; J C Wong; S Engelter; D P Barboriak
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  "T2 washout": an explanation for normal diffusion-weighted images despite abnormal apparent diffusion coefficient maps.

Authors:  S Casey
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome.

Authors:  Florian S Eichler; Paul Wang; Robert J Wityk; Norman J Beauchamp; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

4.  MR brain changes following terpentine oil ingestion.

Authors:  Thomas Seifert; Giorgio Giacomini; Peter Kapeller; Franz Fazekas
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

5.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

6.  Recurrent reversible cerebral edema after long term immunosuppression with tacrolimus.

Authors:  Manuela Reinohs; Torsten Straube; Petra Baum; Jörg Berrouschot; Armin Wagner
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

Review 7.  CT and MR imaging of central nervous system effects of therapy in patients treated for hematological malignancies.

Authors:  Ali Guermazi; Yves Miaux; François Lafitte; Jean Ralph Zahar; Eliane Gluckman
Journal:  Eur Radiol       Date:  2003-12       Impact factor: 5.315

8.  Posterior reversible encephalopathy and alexia without agraphia in a patient with Hashimoto's encephalopathy.

Authors:  Ozlem Kayim Yildiz; Hatice Segmen; Ibrahim Oztoprak; Ertugrul Bolayir; Suat Topaktas
Journal:  Neurol Sci       Date:  2010-01-30       Impact factor: 3.307

9.  Analysis of cyclosporin A-induced reversible cortical blindness by diffusion-weighted magnetic resonance imaging techniques.

Authors:  Shin-ichi Manabe; Satoshi Kashii; Yukio Miki; Yoshihito Honda
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

10.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.